Title Placeholder
Extensive in-house experience supporting pharmaceutical, biotech, and medical device organisations across Switzerland and the EU.
Title Placeholder
I do not operate like a traditional external law firm.
Title Placeholder
Close collaboration with legal, compliance, quality, and business teams.
Title Placeholder
Immediate availability for ongoing or urgent matters.
Title Text...
I support life-sciences companies and law firms as an external in-house counsel, delivering senior legal and compliance expertise — directly and without intermediaries. When your legal or compliance function requires experienced reinforcement, I operate as a fully integrated extension of your in-house team — providing immediate capability, sound judgment, and executive-level reliability.
Title Text...
Your “External In-House Counsel”. Nearly 20 years of life-sciences legal & compliance experience. I provide hands-on interim support fully integrated into your organisation — aligned with internal processes, priorities, and business realities. My role mirrors that of a senior in-house lawyer: My role mirrors that of a senior in-house lawyer: Close collaboration with legal, compliance, quality, and business teams. Practical, business-oriented advice — not abstract legal theory. Immediate availability for ongoing or urgent matters. Clear ownership of issues from assessment to resolution. The result is continuity, speed, and sound judgment — without lengthy onboarding or management overhead.
Publications
Investment Treaty Arbitration and Access to Medicines: post-pandemic developments
In: Swiss Arbitration Association Series on International Arbitration, Selected Papers on International Arbitration, Volume 9 (2026) pp. 53-81, Stämpfli Verlag
Investment Treaty Arbitration and Access to Medicines
In: ASA Bulletin Volume 43, Issue 1 (2025) pp. 7-33, Wolters Kluwers
Potential Impact on life-sciences. Proposed EU data protection regulation: Potential Impact on life-sciences
In: European Pharmaceutical Contractor, Fall 2014
Company Compliance
In: European Pharmaceutical Contractor, Winter 2013
Anmerkung zu EuGH, Urteil vom 26.4.2007, C-348/04Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.
("Remark to the Judgement in Case C-348/04 Boehringer Ingelheim KG u.a. / Dowelhurst Ltd u.a.")
In: GPR Zeitschrift für Gemeinschaftsprivatrecht, Feb. 2008
Die Beurteilung einer marktbeherrschenden Stellung unter besonderer Berücksichtigung des "more economic approach
The assessment of a dominant position in the light of „the more economic approach"")
In: Wirtschaft und Wettbewerb; vol. 56, afl. 12, pag. 1230-1237 / 2006, with Prof. Franz Böni , 2006
The law of abuse - a more economic approach to article 82
Master thesis, Lund University, Sweden 2006
